Dhaliwal 1995.
Methods | Design: Randomised, double blind, two‐period cross‐over study Duration: 2 x 7 days |
|
Participants | Chronic cancer pain N = 35 participants (30 completers: 13 women, 17 men) Mean age 64 years |
|
Interventions |
Rescue medication: paracetamol 300 mg plus codeine 30 mg once or twice every 4 hours |
|
Outcomes | PI: 100 mm VAS and five‐point NRS (0‐4) Doses of rescue medication per day Pain disability index Withdrawals |
|
Notes | Oxford Quality Score: R = 1, DB = 2, W = 1. Total = 4/5 | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Method used to generate sequence not clearly stated |
Allocation concealment (selection bias) | Unclear risk | Method not clearly stated |
Blinding of participants and personnel (performance bias) All outcomes | Low risk | "matching placebos" |
Blinding of outcome assessment (detection bias) All outcomes | Low risk | "matching placebos" |
Incomplete adverse event outcome data‐ patient level | Low risk | > 90% of participants included |
Selective reporting bias for adverse events | Low risk | All AEs included |
Size | Unclear risk | < 50 participants per treatment arm |